title: Effects of erythropoietin stimulating agent (ESA) automated adjustment protocols on hemoglobin levels and mortality in end stage renal disease patients.
authors.affiliation: Dartmouth Medical School, Section of Nephrology & Hypertension, USA.
authors.forename: Luiz M
authors.initials: LM
authors.lastname: Kolankiewicz
authors.forename: David A
authors.initials: DA
authors.lastname: Weinberg
authors.forename: Marcos
authors.initials: M
authors.lastname: Rothstein
authors.forename: Marc S
authors.initials: MS
authors.lastname: Weinberg
mesh_terms: D000740:Anemia / Q000209:etiology; D006397:Hematinics / Q000008:administration & dosage*; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications / Q000401:mortality* / Q000628:therapy; D008991:Monitoring, Physiologic; D006435:Renal Dialysis; D012189:Retrospective Studies
chemical_list: D006397:Hematinics; D006454:Hemoglobins